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Abstract  46 
Healthcare workers (HCWs) are often referred to as the most trusted source of vaccine-47 
related information for their patients. However, the evidence suggests that a number of 48 
HCWs are vaccine-hesitant. This study consists of 65 semi-structured interviews with 49 
vaccine providers in Croatia, France, Greece, and Romania to investigate concerns HCWs 50 
might have about vaccination. The results revealed that vaccine hesitancy is present in all 51 
four countries among vaccine providers. The most important concern across all countries 52 
was the fear of vaccine side effects. New vaccines were singled out due to perceived lack of 53 
testing for vaccine safety and efficacy. Furthermore, while high trust in health authorities was 54 
expressed by HCWs, there was also strong mistrust of pharmaceutical companies due to 55 
perceived financial interests and lack of communication about side effects. The notion that it 56 
is a doctor’s responsibility to respond to hesitant patients was reported in all countries. 57 
Concerns were also seen to be country- and context-specific. Strategies to improve 58 
confidence in vaccines should be adapted to the specific political, social, cultural and 59 
economic context of countries. Furthermore, while most interventions focus on education 60 
and improving information about vaccine safety, effectiveness, or the need for vaccines, 61 
concerns raised in this study identify other determinants of hesitancy that need addressing. 62 
The representativeness of the views of the interviewed HCWs must be interpreted with 63 
caution. This a qualitative study with a small sample size that included geographical areas 64 
where vaccination uptake was lower or where hesitancy was more prevalent and it reflects 65 
individual participants’ beliefs and attitudes toward the topic. As HCWs have the potential of 66 
influencing patient vaccination uptake, it is crucial to improve their confidence in vaccination 67 
and engage them in activities targeting vaccine hesitancy among their patients. 68 
Keywords: Vaccine hesitancy, healthcare workers, patients, Europe  69 
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Introduction  70 
Healthcare workers (HCWs) are considered the most trusted source of vaccine-related 71 
information(1). However, studies are showing that HCWs are losing confidence in 72 
vaccination for their children, themselves, or their patients(2-5). Public health experts refer to 73 
this loss of confidence as “vaccine hesitancy”, which has recently been defined by the SAGE 74 
Working Group on Vaccine Hesitancy as “a behaviour, influenced by a number of factors 75 
including issues of confidence, complacency, and convenience.”(6) Vaccine hesitant HCWs 76 
can have a powerful influence on vaccination decisions, as they might recommend vaccines 77 
less frequently to their patients, and/or otherwise undermine confidence and contribute to 78 
vaccine hesitancy among the general population(2).  79 
The little available research on HCWs’ attitudes is primarily related to seasonal and/or 80 
pandemic influenza vaccines. Most found that HCWs had not taken the influenza vaccine 81 
because of lack of time (7, 8), not feeling at risk of influenza (9, 10), because they 82 
considered they had no medical indication for the vaccine (4, 5), or due to concerns about 83 
safety and efficacy (3, 11).  84 
This research aims to better understand vaccine hesitancy among vaccine providers in 85 
Europe, and explore the nature of their concerns, their perceptions of vaccine-related 86 
information, and their perceived role in responding to vaccine hesitancy.  87 
 88 
Methods 89 
The study was conducted in Croatia, France, Greece and Romania, as these countries 90 
responded to ECDC’s call for interest in participating in the project entitled “Comprehensive 91 
expert opinion on motivating hesitant population groups to vaccinate”. These countries have 92 
very different socio-economic and political backgrounds, allowing a more comprehensive 93 
overview of vaccine hesitancy in various contexts. Semi-structured interviews were 94 
conducted with healthcare providers who advise on vaccination for children, pregnant 95 
women and adults and who were working in one of the selected countries at the time of 96 
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study. Healthcare professionals who only administer the vaccine, after the patient has 97 
already decided to receive it, were not included. Recruitment of participants was done to 98 
include vaccine providers that are either vaccine hesitant or that face vaccine hesitancy in 99 
their practice. The aim was to build a sample of the general population of vaccine providers 100 
in each country to understand what their concerns about vaccines might be and how they 101 
respond to patient hesitancy. Areas with known vaccine hesitancy or low vaccination 102 
coverage were purposively favoured to increase the likelihood of recruiting healthcare 103 
workers either facing hesitancy or being hesitant themselves. The aim was not to determine 104 
levels of hesitancy in healthcare workers. Due to varying quality and quantity of data 105 
available on vaccination coverage rates and vaccine hesitancy in the different countries, 106 
different sampling methods were used in each country. In Croatia and Romania, the 107 
assumption that vaccine hesitancy exists across the whole country was used to select 108 
participants as there was no available data on specific levels of hesitancy in different regions 109 
and populations. In France, MMR vaccine coverage rates were used as a proxy for vaccine 110 
hesitancy. In Greece, this was done by using snowball sampling and first contacting two 111 
vaccine hesitancy vaccine providers. Based on the time and budget available for the study, 112 
and recommended sampling strategies for qualitative research, each country was asked to 113 
recruit approximately 15 HCWs, selected purposively. 114 
A 30-minute interview guide, with a consent form and information sheet, was sent to country 115 
teams for translation and adaptation. The questions, which were not piloted due to time 116 
constraints, were designed to be neutral (i.e. “Have you ever had a patient who was hesitant 117 
or opposed to get himself/herself or his/her children vaccinated?”, “Do you think that some 118 
vaccines which are officially recommended are not necessary?”). Face-to-face interviews 119 
were conducted at a location chosen by the participant, recorded with their approval, and 120 
transcribed removing identifiers such as names and locations using an automated 121 
programme or manually where software was not available. Interviewers in all countries were 122 
trained experienced researchers in qualitative interviewing.  123 
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Sampling methods 124 
Different sampling strategies were used in different countries. In Croatia, a snowball 125 
sampling technique was used to select participants. Vaccination is provided in Croatia by 126 
family doctors, paediatricians, specialist doctors, and epidemiologists. Fifty general 127 
practitioners (GPs) and ten epidemiologists from areas with vaccine hesitancy were 128 
identified from the main general practitioner networks and through the Epidemiological 129 
Society and contacted by mail or telephone. Thirteen GPs and four epidemiologists agreed 130 
to participate.  131 
In France, Montpellier and two surrounding villages (Ganges and Le Vigan) were chosen for 132 
this study due to low vaccine coverage. GPs are responsible for 90% of vaccination while 133 
other physicians such as paediatricians and gynaecologists vaccinate some target 134 
populations. GPs and gynaecologists were arbitrarily selected using a telephone directory 135 
and 142 were contacted through a telephone survey platform. Fourteen vaccine providers 136 
agreed to participate. Eight participants came from an area with <55% MMR vaccine 137 
coverage rates (first dose), three from a 55–75% coverage rate area and five from a 75–80% 138 
coverage rate area. 139 
In Greece, a snowball methodology was employed as vaccination is mostly carried out 140 
privately by doctors and GPs and they are not connected to a national database recording 141 
vaccination coverage and vaccine hesitancy. Two persons who self-identified as being 142 
vaccine-hesitant – one GP, one paediatrician – were starting points and led to the 143 
identification of an additional 19 contacts from their social networks. Six vaccine providers 144 
refused to participate in the study and 15 interviews were conducted. 145 
In Romania, vaccines are either administered by maternity services, paediatricians or by 146 
family doctors who work under the supervision of the National Institute of Public Health, part 147 
of the Ministry of Health. The presidents of Family Doctors Associations in various districts 148 
were contacted with information about the study and asked to share the contact details of 149 
several GPs and/or paediatricians. Twenty-three HCWs were contacted via phone and six 150 
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refused to participate. At the end of each interview, physicians were asked to refer other 151 
vaccine providers who might be interested to participate in the study.  152 
Data analysis 153 
The Vaccine Confidence Project used a deductive approach, based on a comprehensive 154 
literature review, to develop a standardised coding scheme. Country teams reviewed the 155 
scheme and coded the interviews, adding additional codes where needed. Country analyses 156 
were translated into English to allow comparison across the four countries and sent back to 157 
the Vaccine Confidence Project for overall analysis.  158 
Ethics 159 
Ethical approval was obtained from LSHTM Research Ethics Committee, as well as the 160 
Croatian and Romanian ethics committees. No ethics approvals were required in France or 161 
Greece. 162 
 163 
Results 164 
Sixty-five semi-structured interviews were conducted across Croatia (17/65), France (16/65), 165 
Greece (15/65) and Romania (17/65). Most participants were female (66%) and between 25-166 
44 years old (58%). The majority were GPs (72%), with gynaecologists (9%), 167 
epidemiologists (6%), paediatricians (6%) and internal medicine specialists (6%) also 168 
participating (Table 1).  169 
 170 
Table 1: Participants characteristics (n (%)) 171 
 Croatia France Greece Romania Total  
Number of 
participants 
17  16 15 17 65  
Age 25-44yo: 
17 (100%) 
25-44yo: 
3 (19%) 
45-64yo: 
12 (75%) 
65+: 
1 (6%) 
25-44yo:  
8 (53%) 
45-64yo:  
7 (47%) 
*25-45yo:  
10 (59%) 
46-65yo:  
7 (41%) 
25-44yo:  
38 (58%) 
45-64:  
26 (40%) 
65+:  
1 (2%) 
Sex 
 
Females:  
15 (88%) 
Males:  
Females: 
8 (50%) 
Males:  
Females:  
4 (27%) 
Males:  
Females:  
16 (94%) 
Males:  
Females:  
43 (66%) 
Males:  
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2 (12%) 8 (50%) 11 (73%) 1 (6%) 22 (34%) 
Profession GPs:  
13 (76%) 
Epidemiologists: 
4 (24%) 
GPs:  
10 (62.5%) 
Gynaecologists: 
6 (37.5%) 
GPs:  
9 (60%) 
Internal 
medicine:  
4 (27%) 
Paediatricians:  
2 (13%) 
GPs:  
15 (88%) 
Paediatricians: 
2 (12%) 
GPs:  
47 (72%) 
Gynaecologists: 
6 (9%) 
Epidemiologists: 
4 (6%) 
Paediatricians: 
4 (6%) 
Internal medicine:  
4 (6%) 
Average years of 
practice (range) 
5 (1-11) 21 (4-39) 18 (2-35) 17 (2-31) 16 (1-39) 
Type of practice Solo:  
13 (76%) 
Group:  
4 (24%) 
Solo:  
9 (56%) 
Group:  
7 (44%) 
Solo:  
11 (73%) 
Group:  
2 (13%) 
Other:  
2 (13%) 
Solo:  
14 (82%) 
Group:  
3 (18%) 
Solo:  
47 (72%) 
Group:  
16 (25%) 
Other:  
2 (3%) 
Number of 
HCWs practicing 
alternative 
medicine** 
0 (0%) 1 (6%) 0 (0%) 3 (18%) 4 (6%) 
* The age categories used in the baseline questionnaires in Romania were different from the ones used in other 172 
countries 173 
**Alternative medicine was defined as practicing one or more of these activities at work: acupuncture, 174 
homeopathy, anthroposophy, natural medicine 175 
 176 
The coding themes identified across all countries included: perceived benefits of vaccination 177 
(mentioned 227 times across all interviews – more than one mention per interview is 178 
possible), issues with vaccination (201), role of HCWs in responding to patient hesitancy 179 
(197), trust issues (139), suggestions to improve vaccine confidence (127), quality of 180 
information and communication (120), and decision-making influences (115).  181 
HCWs in all four countries identified the following benefits of vaccination: benefits outweigh 182 
risks of vaccination (Croatia(C)=17; France(F)=12; Greece(G)=8; Romania(R)=13), vaccines 183 
prevent dangerous diseases and current outbreaks constitute the best example of the 184 
dangers of not vaccinating (C=16;F=10; G=8;R=10). One HCW in Romania explained: 185 
“Vaccines have been used for a long time now (…). They have achieved their purpose: to 186 
prevent disease, to maintain health status, and to stop recurrence of diseases that have life-187 
long sequelae” (R6). Many HCWs, particularly in France, Romania and Croatia also 188 
emphasised the benefit of herd immunity (C=15; F=11; G=2; R=10), and the responsibility 189 
people (including doctors) have to protect the entire society. As one French participant 190 
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noted, “I consider that those people who refuse vaccination are selfish because they take 191 
advantage of the vaccination of other people” (F1). A large number of HCWs in Romania 192 
and Croatia supported vaccination due to the existence of good scientific evidence (C=15; 193 
F=3; G=4; R=10).  194 
Concerns about the safety of vaccination was the most recurrent theme in Romania and in 195 
Greece, and was raised by a small number of HCWs in France and Croatia, with some 196 
reporting patients’ perceptions of risks. The most common concern reported, particularly in 197 
Greece and Romania was about side effects (C=5; F=3; G=9; R=14), including feelings of 198 
guilt if patients were to suffer from vaccine adverse events. A few HCWs had severe worries, 199 
as one from Romania concluded, “It's well known that there are vaccines that have been 200 
banned in other countries (e.g., anti-hepatitis), precisely because they were proven to cause 201 
multiple sclerosis. (…) HPV vaccines can lead to tumours and autism. It's outrageous that 202 
they are prescribed” (R9). Concerns that new vaccines, such as HPV, might not have been 203 
tested long enough were also raised. Issues of low vaccine effectiveness, or beliefs that 204 
vaccines (i.e. influenza) do not always work were particularly common in Greece, which 205 
sometimes led HCWs to avoid recommending vaccines (C=2; F=4; G=10; R=4). One noted, 206 
“I recommend some vaccines at a later stage than what is recommended to avoid over-207 
stimulating their immune system” (G11).  Many HCWs in Romania and Greece also 208 
mentioned that there might be too many vaccines (C=1;F=2;G=11;R=5) given to children at 209 
a very young age (C=1;F=3;G=6;R=2), which led some interviewed doctors to follow their 210 
own vaccination plans in Greece.  211 
Trust issues were raised in Greece, Romania, and Croatia and to a lesser extent in France. 212 
In Croatia, France and Romania, the majority of these positively referred to trust in the 213 
government, health authorities, doctors or research (C=17;F=8;G=6;R=12), and in 214 
vaccination (C=17;F=4;G=5;R=11). In Croatia and Greece, trust in information received by 215 
HCWs from various sources was also observed. Mistrust was extremely prevalent in Greece, 216 
especially towards pharmaceutical companies (C=2;F=4;G=11;R=7). Interviewed HCWs in 217 
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all countries believed pharmaceutical companies have financial interests, put pressure on 218 
HCWs, and do not provide sufficient information about side effects. A mistrust of health 219 
authorities (C=0;F=3;G=9;R=4) and information about vaccination (C=0;F=3;G=7;R=6) was 220 
also observed among some of the interviewed French, Romanian and Greek HCWs. One 221 
Greek respondent commented, “I do not trust the Greek Ministry of Health and rightly so. 222 
Many patients do not trust them either.” (G12).  223 
HCWs in Croatia and Romania were particularly pleased with the quantity and quality of 224 
information they receive or give to patients through leaflets, posters, books or websites 225 
(C=13;F=1;G=3;R=11). However, other HCWs in Romania and in Greece also reported a 226 
lack of information about safety and the risks of receiving too many vaccines to allow 227 
patients to make an informed decision (C=4; F=2; G=8; R=7). A few doctors in Greece and 228 
Romania (C=0, F=0, G=4, R=3) were also entirely against vaccination, two of which also 229 
mentioned a preference for homeopathy or prescribing natural remedies. “I do not like 230 
vaccines! I tell my patients that I’ve never vaccinated myself with any vaccine.”(R1). 231 
HCWs in Romania, Greece and France, and to a lesser extent in Croatia, discussed ways 232 
they and their patients are influenced when making decisions about vaccination. HCWs in all 233 
countries reported being influenced by their employers or health authorities in terms of 234 
vaccination schedules or reminders (C=11; F=9; G=4; R=10). Influences by pharmaceutical 235 
representatives who remind HCWs of vaccination schedules were mostly discussed in 236 
France (C=0; F=12; G=0; R=2), where mistrust in pharmaceutical companies was not 237 
reported as much as in other countries. One French HCW commented, “Pharmaceutical 238 
drug representatives visit me; they explain to me how vaccines work, why a vaccine more 239 
than another…” (F6), while another expressed some distrust. “I listen to (pharmaceutical) 240 
companies but do not trust them” (F5). This shows that HCWs in France receive visits by 241 
pharmaceutical representatives and use the information they provide, but do not necessarily 242 
trust them. Influences from patient experiences (i.e. observing a lack of vaccine side effects 243 
or infections with vaccine-preventable diseases) were reported in Greece and Romania. 244 
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Other influences mentioned were training courses, the media, online information, and 245 
medical experts and journals. Some HCWs in Greece and Romania believed that their 246 
patients were influenced by the media (C=0;F=1;G=3;R=13), HCWs (C=0;F=0;G=14;R=0), 247 
and families, friends or partners (C=0;F=0;G=3;R=1). HCWs in Romania discussed the 248 
negative, unverified and sometimes contradictory information available online which is 249 
sometimes more persuasive than doctors: “With the increasing popularity of the Internet, 250 
many parents are misinformed by charlatans and crooks that "seduce" them with false and 251 
absurd information. (…) If some doctors were fooled by such misinformation, then parents 252 
(…) are very vulnerable to such poisoning.”(R5) 253 
HCWs in all countries discussed their role in responding to patient hesitancy. In Croatia, 254 
Greece and Romania, HCWs mostly believed that it is their role to address and respond to 255 
patient hesitancy (C=17; F=4; G=13; R=11) by sharing “accurate and reliable information in 256 
a way that they can understand” (C3). Some HCWs in Croatia, France and Romania, went 257 
one step further and explained they have to try to influence patients’ decision-making 258 
regarding vaccination by emotionally affecting them (i.e. showing them images of 259 
poliomyelitis cases), telling them they vaccinate their own children, or telling them 260 
vaccination is mandatory (C=10; F=6; G=3; R=10): “I say it is mandatory even if it is not... 261 
(…) I don't want to follow a child, a family who do not vaccinate their children” (F16).  Some 262 
HCWs, mostly in France, believed they should only provide neutral facts and information 263 
about vaccination, without trying to influence or force patients to vaccinate (C=1; F=10; G=3; 264 
R=4).  265 
Overall, across all countries, HCWs came up with four major suggestions to improve 266 
vaccination confidence: improve information, involve health authorities, ensure skilled 267 
communication between HCWs and patients, and improve HCW training.  268 
Discussion 269 
The results from the qualitative interviews with HCWs from Croatia, France, Greece and 270 
Romania confirm the study’s initial assumption of existence of vaccine hesitancy among 271 
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HCWs and provide an insight into the reasons behind these doubts. Although the reports 272 
from the interviews were overall positive and showed generally high levels of trust and 273 
confidence in vaccination, there were also concerns about safety, questions about the need 274 
for vaccines, and/or mistrust of pharmaceutical companies and health authorities. A few 275 
doctors, some practicing homeopathy, were entirely against vaccination, and actively 276 
decided not to recommend it to their patients. This is of particular concern as many studies 277 
have shown that the attitude and knowledge HCWs have about vaccines can influence their 278 
intentions to vaccinate themselves and their children, and to recommend vaccination to their 279 
patients (12, 13). It is therefore highly important for public health leaders to find ways to 280 
better understand HCW vaccine-related behaviours and attitudes and take steps to counter 281 
hesitancy.  282 
The most important concern across all countries was about vaccine safety. Most HCWs 283 
reported these as concerns their patients have, but some shared similar worries. Many 284 
studies have found that HCWs refuse vaccination because of the risk of side effects (11), but 285 
also because they think they are at low risk of infection (15, 16). The latter was also 286 
observed in this study, with HCWs lacking confidence in the need for and the effectiveness 287 
of some vaccines, particularly the seasonal influenza one. HCWs have their patients’ health 288 
at heart, and it important that they are reminded of the dangers of vaccine-preventable 289 
diseases and the low risks of vaccine side effects. 290 
New vaccines, such as the HPV vaccine, were singled out due to perceived lack of testing 291 
for vaccine safety and efficacy. This confirms previously conducted studies which also 292 
showed HCWs’ concerns about new vaccines (17, 18). The HPV vaccine is of particular 293 
concern, as it is delivered by different HCWs in different countries. Making sure all vaccine 294 
providers (nurses, gynaecologists, GPs, etc.) are included in the planning and deployment of 295 
new vaccination campaign will alleviate their doubts and concerns, improve their knowledge 296 
about the vaccine, and facilitate their recommendation to patients.  297 
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Another important theme which came across the interviews was trust. A 2015 French study 298 
found that eight out of ten GPs trust the Ministry of Health but 50% of them also believe that 299 
the Ministry is influenced by pharmaceutical companies (19). A similar scenario was found in 300 
this study, with high trust expressed in the health authorities but mistrust of pharmaceutical 301 
companies. Interviewed HCWs in Greece also showed high mistrust of the government and 302 
health system, which could have been influenced by the political and economic crisis 303 
situation in which the interviews were conducted and may require interventions to avoid 304 
negative impact on vaccination uptake. This result demonstrates the importance of context in 305 
vaccine hesitancy, and highlights the need for more cross-cutting research looking into the 306 
impact of political, socio-economic and cultural contexts on concerns about vaccination. 307 
Many institutions can be associated with vaccination and the public’s credibility of vaccine 308 
information will be influenced by their trust in some or all of these organisations and how 309 
open and transparent these are. Trust can be built by expressing empathy and 310 
acknowledging people’s concerns and feelings and depends on the specific social, cultural, 311 
political and economic context of the country or region affected.  312 
HCWs stressed the issue of anti-vaccination content in the media and its influence on 313 
patients. With continuous advancements in communication technologies such as social 314 
media, the public is increasingly using the internet to research and share information about 315 
vaccines. Some studies have analysed the content of vaccine information available on 316 
websites and social media and have shown not only that it is of variable quality, but also that 317 
there is a predominance of negative and sometimes incorrect content, which has the 318 
potential to influence vaccine decisions (21-24). However, a study looking particularly at 319 
French websites found that while some websites criticise some aspects of vaccines, not all 320 
disseminate anti-vaccination opinions (25). National authorities and governments should 321 
consider taking advantage of what online media, including social media, have to offer by 322 
promoting and sharing clear, concise and easy to understand information about vaccination. 323 
Increasing the presence of reliable sources of information online will allow countries to 324 
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counteract anti-vaccine groups and prevent them from reaching parents seeking more 325 
information about vaccines on the internet.  326 
Many interviewed vaccine providers felt it was their responsibility to respond to hesitant 327 
patients, with some believing they should do even more and try to actively influence patients 328 
to ensure they get vaccinated. However, in France, most study participants described their 329 
role as providers of neutral information, explaining patients should make that decision for 330 
themselves. HCWs are often seen as having the greatest influence on patients’ decision to 331 
get vaccinated. It is therefore important they not only communicate with hesitant patients, but 332 
that they know how to respond to concerns or doubts. A study from 2011 concluded that 333 
HCWs should aim to have open, non-confrontational dialogues with patients as early as 334 
possible. It recommended using personal stories, reports of disease outbreaks and visual 335 
images of individuals suffering from vaccine-preventable diseases to remind patients of the 336 
need for high vaccination coverage (26).  337 
This study sheds light on current knowledge gaps that future research could explore further 338 
such as varying opinions about vaccination among different types of vaccine providers, but 339 
also in relation to different vaccines. The wide range of concerns raised related to vaccine 340 
hesitancy points to the need for more comprehensive, context-specific interventions. While 341 
most current interventions focus on education and improving information about vaccine 342 
safety, effectiveness, or the need for vaccines, concerns raised in this study identify other 343 
determinants of hesitancy that need addressing, such as trust in health systems, or HCWs’ 344 
perceived roles in responding to patient hesitancy and their levels of confidence in doing so. 345 
Although some commonalities between countries can be found, determinants of hesitancy 346 
have also been shown to be country- and context-specific and need to be addressed as 347 
such. National vaccination programmes should consider developing the capacity of 348 
identifying local determinants of vaccine hesitancy, whether in patients or in healthcare 349 
workers and then developing strategies adapted to address these determinants, in a social, 350 
cultural, political and economic context.  351 
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 352 
Limitations 353 
There were a few limitations in this research. The first is the limited sample size and 354 
differential sampling strategy in each country which may have affected the reliability of the 355 
study. Recruitment of HCWs was also intentionally biased as it was done in geographical 356 
areas where vaccination uptake was lower than average or where hesitancy was reported to 357 
be more prevalent. Results for Greece must also be interpreted with caution as it was the 358 
only country were vaccine hesitant providers were directly recruited through snowball 359 
sampling. The representativeness of the views of the HCWs interviewed in this study must 360 
be interpreted with caution, especially as they come from different healthcare systems, with 361 
different approaches to vaccine provision. That said, the study’s intent was to start 362 
identifying the characteristics and experience of hesitancy among HCWs where vaccine 363 
hesitancy and low vaccine uptake was known rather than quantify vaccine hesitancy. HCWs 364 
from different countries might also have answered questions differently, due to the influence 365 
of vaccination legislation in their country, which might have led to underreporting of some 366 
perceived issues. Fear of reprisal might have also deterred some HCWs from sharing their 367 
concerns about vaccination.  368 
 369 
 370 
Appendix 371 
Topic guide for the semi-structured interviews 372 
BASELINE INFORMATION 373 
 374 
1. What is your gender? 375 
 Male   Female 376 
 377 
2. What is your age? 378 
 ≤24   25-44  45-64  65+ 379 
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 380 
3. What is your profession? 381 
 General practitioner (family doctor)  Nurse/midwife  382 
 Specialist, please specify        Other, please specify       383 
 384 
4. Where do you currently work (what type of health institution) and how long have 385 
you been working there? 386 
      387 
 388 
5. Do you practice alternative medicine at work (acupuncture, homeopathy, 389 
anthroposophy)? If yes, could you shortly explain what it entails? 390 
 No   Yes,       391 
 392 
VACCINATION PERCEPTIONS AMONGST HEALTH CARE PROVIDERS 393 
For each question, sub questions are there to direct or redirect the 394 
conversation if necessary.  395 
 396 
6. Do you ever explain to patients that getting vaccinated is not only important to 397 
protect themselves but also others? Why? 398 
 How do patients usually respond? 399 
      400 
 401 
7.  Did you receive last season’s influenza vaccine?  402 
 What were your reasons for accepting/refusing? 403 
 Did you experience any doubt or concern about the vaccine and if so what were 404 
they? 405 
 In your opinion, should healthcare workers get vaccinated against influenza every 406 
season? 407 
      408 
 409 
8. Do you have children? If so, are your children/is your child vaccinated with the 410 
national recommended vaccinations (according to the national immunisation 411 
schedule)?  412 
 How difficult was it for you to make the decision to vaccinate your child/children 413 
compared to vaccinating yourself or patients? 414 
 Did you experience any doubt or concern about a particular vaccine recommended to 415 
your children and if so, what were they (for which vaccines)? 416 
 Are there some vaccines you offer to your patients but you would not vaccinate your 417 
children with? 418 
      419 
 420 
9. Do you personally give advice to patients on vaccination and if so, what influences 421 
the content of your advice? 422 
 Where do you seek information on vaccines and who do you trust the most? (Fellow 423 
doctors, health authorities, health agencies, medical press, internet, pharmaceutical 424 
companies, friends and family, others)(Please specify)? 425 
      426 
 427 
 428 
10. In your opinion, does your workplace offer patients enough advice and 429 
information about vaccination? 430 
 What material is available for patients, and what resources are they redirected to? 431 
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 Do you think colleagues take or have enough time to dedicate to discuss patients’ 432 
concerns? 433 
 Have you ever disagreed/provided conflicting advice with a colleague?  434 
 Are any of your colleagues against vaccination? If so, why and how did you respond 435 
to their claims? 436 
      437 
 438 
11. Have you ever had a patient who was hesitant or opposed to get himself/herself or 439 
his/her children vaccinated?  440 
 Could you describe what happened, why was the patient hesitant or opposed and 441 
how did you respond?  442 
 Did you feel comfortable to answer his/her questions/concerns? And why? 443 
 Did you have access to information/resources that helped you to address these 444 
concerns? Which ones? 445 
 Did you feel like you agreed or shared some of their doubts and concerns?  446 
 After speaking with this patient, did you re-consider your views on vaccines and 447 
vaccine safety? 448 
      449 
 450 
12. How confident are you that vaccinated individuals have more benefits from 451 
vaccinations than rare severe adverse events? 452 
 What are your concerns or worries about vaccine safety? 453 
 What about new vaccines or vaccines for pregnant women? 454 
 Could you rank your biggest concerns in order of importance? 455 
 Would you feel responsible if something were to happen to your patient after 456 
immunisation? 457 
      458 
 459 
13. Are there any particular vaccines about which you have safety concerns? 460 
 Which vaccines and which concerns? 461 
 Do you recommend them to patients? Why/why not?  462 
 Have you ever recommended to a patient that he/she should not get vaccinated 463 
(please give examples and reasons explaining the advice you gave patients)? 464 
      465 
 466 
14. Do you think that some vaccines which are officially recommended are not 467 
necessary? If yes, which vaccines? 468 
 How concerned are you that some vaccines might not prevent the disease?  469 
 How effective/necessary do you think vaccines are?  470 
 Do you think children receive too many vaccines? 471 
      472 
 473 
15. Do you think there is a need to improve vaccination confidence and uptake 474 
amongst health care professionals and patients, and if so, how do you think it could 475 
be improved?  476 
 Which tools, training, information, or communication skills do you think you would 477 
need to improve vaccination uptake? 478 
 Where, from which organisations do you think you could find support to do this? 479 
       480 
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